Skip to main content
. 2004;6(Suppl 7):S3–S11.

Figure 2.

Figure 2

In Study INT 0036, conducted by the Southwest Oncology Group, patients who received combination therapy with leuprolide and flutamide experienced a 26% increase in survival compared with patients receiving leuprolide plus placebo (35.6 months vs 28.3 months, respectively).18 NCI, National Cancer Institute.